Stanelco PLC
01 October 2004
1 October 2004
Stanelco plc
High Court rules Stanelco entitled to 2 patent families
Stanelco Fibre Optics Limited ('SFOL'), a subsidiary of Stanelco plc, and
BioProgress Technology Limited ('BioProgress') had a brief period of interaction
during 1998. Five years after the interaction ended BioProgress sent SFOL a
letter before action claiming that it was entitled to three families of patents
owned by SFOL relating to the formation of capsules and also that SFOL had
breached confidence. During October 2003 SFOL initiated High Court proceedings
against BioProgress and the case was heard in the High Court in July of this
year.
The outcome of the litigation has been that SFOL has succeeded in confirming
that it is solely entitled to two of the three patent families (including SFOL's
patent family for making capsules using a rotary die process which is the most
commercially significant application for capsule manufacture) and jointly
entitled to two of the claims of the other patent family. The remaining claims
of this patent family have been found to belong to BioProgress. The Court has
also found in BioProgress' favour in relation to part of its claim for breach of
confidence by virtue of SFOL's use of certain information as the basis for its
patent applications.
Commenting on the court's decision, Stanelco Chief Executive Ian Balchin said
'We are obviously pleased to have won outright on our entitlement to two of the
three patents families. We disagree with the court's reasoning in relation to
the remaining issues. However, we believe that we have good prospects of
appealing the court's decision and this is the course we will be following.
Stanelco's business has continued to develop since the action was brought, with
a number of new applications for our RF technology - which do not rely upon
these patents. These include food tray lidding, which now represents a very
significant part of Stanelco's future projected revenues.'
A full copy of the Judgment will be available in due course from the Court's
website at http://www.courtservice.gov.uk/judgments/judg_home.htm
For further information please contact:
Ian Balchin, Chief Executive
Stanelco PLC
Tel- +44 (0)2380 867 100
Jonathon Brill/Billy Clegg
Financial Dynamics
Tel- :+44 (0) 207 831 3113
Notes to Editors:
Stanelco was founded in 1953 and is a world leader in the development of radio
frequency technologies for processing polymers for edible and packaging
applications and the design and manufacture of optical fibre technology,
induction heating and dielectric welding equipment. The Company's current core
business is the manufacture of optical fibre using Radio Frequency (RF)
technology. Stanelco has been applying its technology to other markets. Current
developments include biodegradable air cushion packaging, sealing of low-cost
conventional plastics for food packaging, water-soluble detergent capsules,
foamed starch trays, edible sachets and waste packing.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.